Method Security
AI NativeFull-spectrum security products for cyber resilience.
Est 2023|Valuation $125M|Raised $50.5M
Published Sep 26, 2026
Method has announced early-stage funding and reported government traction, which indicate vendor momentum in the dual-use / national-security cyber segment. However, adoption trends relative to CTEM/BAS category leaders cannot be quantified from public sources reviewed.
| Category fit | Broad platform combining exposure management and offensive operations | Exposure validation / BAS (agentless packages, adversary emulation) | BAS / exposure validation with CTEM positioning |
| Starting Price | Not public (demo / enterprise engagement) | Free tier; pay-as-you-go options; Flex plans with documented pricing tiers | Pricing varies by source; references indicate bundle and enterprise pricing |
| Most appropriate for | High-stakes teams seeking a unified platform and automated workflows across domains | Teams seeking fast, production-safe exposure validation with self-serve options | Organizations seeking structured BAS/validation across multiple threat vectors with established vendor support |
| Key Strength | Unified ontology/digital twin and convergence of offensive and defensive capabilities; positioning for critical institutions | Self-contained tests and accessible entry pricing for some products | Broad vector coverage and more established vendor footprint |
| Key Weakness | Limited public reviews and case studies; pricing and compliance posture not clearly public | More focused on validation rather than full exposure-graph management | Can be costly at enterprise scale and may function primarily as a validation point solution |
Where Method may be most applicable:
Where competitors may be stronger: